Phibro Animal Health (PAHC) Non Operating Interest Expenses (2013 - 2026)

Phibro Animal Health has reported Non Operating Interest Expenses for 7 years, with the latest figure at $10.7 million in Q2 2026.

• On a quarterly basis, Non Operating Interest Expenses rose 18.64% year-over-year to $10.7 million in Q2 2026; TTM through Jun 2026 was $46.4 million, a 24.69% increase from a year earlier, with the FY2026 full-year figure at $46.4 million, up 24.69% from the prior year.
• Non Operating Interest Expenses was $10.7 million for Q2 2026 at Phibro Animal Health, roughly flat from $10.7 million in the prior quarter.
• The five-year high for Non Operating Interest Expenses was $12.5 million in Q3 2025, with the low at $5.6 million in Q3 2023.
• Average Non Operating Interest Expenses over 4 years is $8.9 million, with a median of $9.3 million recorded in 2025.
• The sharpest annual moves came in 2025 and 2026: Non Operating Interest Expenses soared 71.0% in 2025, then gained 10.65% in 2026.
• Over 4 years, Non Operating Interest Expenses stood at $5.7 million in 2023, then jumped by 70.85% to $9.8 million in 2024, then advanced by 27.64% to $12.5 million in 2025, then retreated by 14.18% to $10.7 million in 2026.
• The last three Non Operating Interest Expenses figures came in at $10.7 million (Q2 2026), $10.7 million (Q1 2026), and $12.5 million (Q4 2025), per Business Quant data.